Search research articles
Contact Us
Filters
Showing results (601-610 of 755) with videos related to
Page
of 76
Sort By:
The Lancet. Rheumatology
|
November 8, 2023
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease
Michael Hughes, Yannick Allanore, Murray Baron, et al.
Arthritis and Rheumatism
|
April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
The Journal of Rheumatology
|
August 3, 2011
Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop
Clifton O Bingham, Rieke Alten, Susan J Bartlett, et al.
Clinical and Experimental Rheumatology
|
May 19, 2011
Quality indicator set for systemic sclerosis
Dinesh Khanna, Otylia Kowal-Bielecka, Puja P Khanna, et al.
Arthritis and Rheumatism
|
September 2, 2006
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Xuebing Feng, Hui Wu, Jennifer M Grossman, et al.
BMJ Open
|
March 8, 2018
Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study
Erin L Merz, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Journal of Scleroderma and Related Disorders
|
May 19, 2017
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 25, 2019
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
Elizabeth R Volkmann, Donald P Tashkin, Masataka Kuwana, et al.
Journal of Scleroderma and Related Disorders
|
December 21, 2018
Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition
Y A Suliman, C Bruni, S R Johnson, et al.
Annals of the Rheumatic Diseases
|
April 7, 2007
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study
Daniel E Furst, Norman Gaylis, Vance Bray, et al.
Page
of 76
Search research articles
Search
Showing results (601-610 of 755) with videos related to
Sort By:
Page
of 76
The Lancet. Rheumatology
|
November 8, 2023
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease
Michael Hughes, Yannick Allanore, Murray Baron, et al.
Arthritis and Rheumatism
|
April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
The Journal of Rheumatology
|
August 3, 2011
Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop
Clifton O Bingham, Rieke Alten, Susan J Bartlett, et al.
Clinical and Experimental Rheumatology
|
May 19, 2011
Quality indicator set for systemic sclerosis
Dinesh Khanna, Otylia Kowal-Bielecka, Puja P Khanna, et al.
Arthritis and Rheumatism
|
September 2, 2006
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Xuebing Feng, Hui Wu, Jennifer M Grossman, et al.
BMJ Open
|
March 8, 2018
Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study
Erin L Merz, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Journal of Scleroderma and Related Disorders
|
May 19, 2017
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna, Daniel E Furst, Philip J Clements, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 25, 2019
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
Elizabeth R Volkmann, Donald P Tashkin, Masataka Kuwana, et al.
Journal of Scleroderma and Related Disorders
|
December 21, 2018
Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition
Y A Suliman, C Bruni, S R Johnson, et al.
Annals of the Rheumatic Diseases
|
April 7, 2007
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study
Daniel E Furst, Norman Gaylis, Vance Bray, et al.
Page
of 76